CTSO

NASDAQStock

Cytosorbents Corporation

$0.70-0.02 (-3.39%)

52-Week Range

$0.62

$1.29

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.40

Volume

28.7K

Avg Volume

66.6K

Performance

+13.14%

+15.91%

-20.17%

YTD

+10.66%

-35.78%

-77.67%

-92.27%

Price Chart

ETF Exposure

CTSO is held by 10 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.16%	2,978	$21K	$13.0M	—
STSB	iShares Factors US Small Blend Style ETF	0.02%	152	$1K	$7.3M	0.35%
IWC	iShares Micro-Cap ETF	0.01%	146,437	$106K	$1.27B	0.60%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	62	$53	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,238	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	10	$9	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,274,363	$803K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	6,702	$6K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	577	$493	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	536,973	$338K	$84.10B	0.05%

About CTSO ETF Exposure

Cytosorbents Corporation (CTSO) is held by 10 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.70. Investors can gain exposure to CTSO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CTSO, sorted by portfolio weight.